Weybosset Research 13F Filed April 16

Weybosset Research & Management LLC submitted its Form 13F on April 16, 2026, disclosing quarterly equity positions as of the March 31, 2026 reporting date (source: Investing.com, Apr 16, 2026; SEC Form 13F). The filing is a routine statutory disclosure but offers a contemporaneous snapshot of the firm’s public-equity posture at the start of Q2 2026. For institutional investors and allocators, quarter-end 13Fs remain one of the most direct windows into portfolio shifts—especially changes in large-cap public-equity allocations and concentrated positions. This piece outlines the filing’s mechanics, interprets what the timing and content typically indicate, and situates Weybosset’s disclosure in the broader market and regulatory context. Where possible we reference primary filings and SEC rules; readers can access the reported 13F via the SEC’s EDGAR database or the Investing.com recap (Investing.com, Apr 16, 2026).

Context

Form 13F is required of institutional investment managers that exercise investment discretion over at least $100 million in Section 13(f) securities (SEC rule threshold: $100 million, SEC.gov). The report must list equity holdings as of the quarter end and be filed within 45 days; Weybosset’s April 16 filing conforms to the statutory timeline for the March 31 quarter end (45-day window; SEC rule, Form 13F). Because 13Fs report positions at a point-in-time, they do not capture intra-quarter trading or derivatives exposure, and they omit many asset classes such as most fixed income, private equity, and non-13(f) listed securities. Investors should therefore treat the filing as a delayed but standardized disclosure rather than a complete view of risk or strategy.

Weybosset Research’s filing should be read alongside other contemporaneous public disclosures to form a full picture. Quarterly 13Fs are comparable across managers because of the uniform reporting format: number of shares, issuer, CUSIP, and position value in USD. That comparability makes 13Fs a common input for cross-sectional analysis of sectors, factor tilts, and concentration. However, 13Fs can understate headline activity in firms that use derivatives or significant short positions—areas where Weybosset’s broader SEC filings or commentary (if available) would be necessary to reconcile gross vs net exposures.

From a timing perspective, filings like Weybosset’s on April 16 provide a useful timeline marker. Market participants often track a cluster of 13F submissions in mid-April (for March quarter-end) to detect crowded trades or systematic shifts into or out of mega-cap names. The filing date itself—April 16, 2026 in this case—does not indicate when trades occurred but it does set a disclosure baseline for quarter-end positions against market benchmarks such as the S&P 500 (SPX) or sector indices.

Data Deep Dive

The Weybosset 13F filing dated April 16, 2026 reports holdings as of March 31, 2026 (Investing.com, Apr 16, 2026; SEC EDGAR). This filing conveys at least three quantifiable, verifiable datapoints: the filing date (Apr 16, 2026), the reporting date (Mar 31, 2026), and the regulatory timeline constraint (45 days after quarter end per SEC Form 13F instructions). These three points frame any subsequent analysis because they anchor the positions to a market snapshot and a compliance schedule.

A second set of useful metrics that 13Fs provide are position concentration measures: number of distinct CUSIPs reported, aggregate market value of the 13(f) holdings, and the share of portfolio represented by the top five or top ten positions. While Weybosset’s precise counts and values are accessible in the filing, the investor takeaway is predictable: high top-ten concentration suggests a concentrated public-equity strategy, while a long tail across many CUSIPs suggests a diversified public-equity sleeve. Comparing the top-ten concentration against a peer group (for example, other hedge funds or long-only managers that filed contemporaneously) provides a relative-risk measure.

For institutional users, two additional numbers are routinely extracted: turnover implied by quarter-to-quarter changes in share counts and the directional change in sector weights versus benchmark indices. A large increase (for example, a 5–10 percentage-point jump in sector weight from one quarter to the next) can signal a tactical rotation or sector-specific conviction. Conversely, minimal change suggests a steady-state allocation or longer investment horizon. Analysts should corroborate any major shifts in the 13F with market events in the reporting window to separate opportunistic trading from structural rebalancing.

Sector Implications

When a manager with Weybosset’s profile files a 13F, the sector-level moves implied by the filing can have signaling value for market participants. If the filing shows a sizable overweight in technology, for example, that could be read relative to the S&P 500 weight for technology (a benchmark comparison). Historically, large-cap concentration moves by institutional managers have amplified short-term flows into passive vehicles tracking the same market-cap-weighted baskets. That mechanical channel remains important: changes in reported holdings translate into buying or selling pressure when mirrored by ETFs and index-first allocators.

A second channel is peer benchmarking. Many allocators monitor the 13Fs of multiple managers to build composite sentiment indicators across a sector. If several managers filed on April 16 showing cumulative reductions in financials and increases in healthcare exposure, the composite signal could be interpreted as a broader rotation. Such cross-manager comparisons are particularly informative when read year-on-year (YoY) — for example, comparing Q1 2026 sector weights to Q1 2025 to understand strategic shifts tied to macro regime changes.

Finally, the absence of exposure to a high-profile issuer can be as informative as the presence of one. A notable omission of a mega-cap stock from a previously reported position can indicate liquidation, hedging via derivatives, or repositioning into private opportunities. Practitioners therefore use 13F data both to identify crowded long positions and to detect structural de-risking at the sector level.

Risk Assessment

Interpreting a single 13F requires caution. The primary risk in reading Weybosset’s filing is over-attribution: assuming the entire economic exposure is captured in the reported line items. 13Fs exclude short positions in most cases, and they do not reflect derivatives that can materially alter net exposure. For example, a manager may show a long shareholding in a name while simultaneously hedging via options or swaps—an activity that would not be visible in the 13F. Institutional users must reconcile 13F data with other filings (13D/13G, 10-K/10-Q disclosures if applicable) and with market price action to better estimate net portfolio beta.

A second risk is timing mismatch. The March 31 snapshot can miss rapid market re-pricing or tactical rotation that occurred in April; therefore, the filing is backward-looking and can mislead if treated as contemporaneous. In highly liquid mega-cap names, this lag matters less for understanding long-term allocations but can be decisive for interpreting short-term trading flows. For events or catalysts that occurred in early April 2026, the 13F may understate the manager’s response.

Operationally, reliance on a single manager’s 13F for sector allocation decisions is also risky. Peer comparisons and aggregate 13F-derived indices reduce idiosyncratic noise. Platforms that aggregate filings across managers provide a more robust signal and allow for cross-checks against fund-level returns, investor flows, and benchmark performance.

Outlook

Weybosset’s April 16, 2026 filing is a datapoint in a sequence of quarterly disclosures that, when trended, reveal allocation choices and concentration dynamics. Over the medium term, market participants will look for persistence in top holdings and sector tilts across subsequent filings to determine whether observed positions reflect tactical trades or enduring strategy. If a manager’s top-five positions persist across two or more filings, that persistence increases the probability the positions are strategic rather than opportunistic.

From a market-impact standpoint, individual 13F filings rarely move broad indices alone, but they can influence stocks with modest free float or where reported positions represent a meaningful share of outstanding shares. That assessment requires comparing the reported position size to outstanding float and recent liquidity metrics. Professionals often calculate position-to-float ratios and average daily volume multiples to estimate potential execution impact if positions were to be rebalanced.

Practically, asset allocators and risk teams will integrate Weybosset’s disclosed positions into portfolio-level stress tests and correlation matrices. Combining 13F disclosures with factor exposures and macro overlays helps estimate how an institutional sleeve may contribute to portfolio volatility under alternative scenarios.

Fazen Markets Perspective

Weybosset’s filing is not an isolated signal; it is most valuable when triangulated with contemporaneous macro data, fund flows, and peer 13Fs. A contrarian insight: because 13Fs are public and predictable in timing, some sophisticated managers intentionally stagger or camouflages trades using derivatives and non-13(f) instruments to avoid signaling. Therefore, a lack of change in a 13F can sometimes indicate deliberate opacity rather than stasis. We advise using 13Fs as a directional input rather than a definitive map of exposures and combining them with intraday market microstructure metrics and alternative data to detect concealed activity. For institutional users focused on liquidity and crowding, a deeper read of position-to-float ratios and implied turnover across filings often uncovers more risk than headline concentration figures alone.

For further resources on interpreting quarterly filings and implementing 13F signals into risk frameworks, see our research center and model guides at topic. Our data team maintains a rolling 13F aggregation tool to watch cross-manager concentration over time—available through the institutional research portal topic.

Bottom Line

Weybosset Research’s April 16, 2026 Form 13F provides a compliance-mandated snapshot of its public-equity positions as of March 31, 2026; the filing is informative but inherently limited by timing and scope. Use it as one input among many—corroborated with other filings, market data, and liquidity metrics—when assessing manager exposures.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.

FAQ

Q: Does a Form 13F show short positions or derivatives? A: No. Form 13F lists long positions in Section 13(f) securities as of the quarter end and does not require disclosure of short positions or most derivatives. For derivative exposures, investors must consult other filings or discretionary disclosures.

Q: How quickly can market participants act on 13F information? A: The information is public and typically posted on EDGAR and financial news services within days of filing (Weybosset filed Apr 16, 2026). Because filings are backward-looking to the quarter end (Mar 31), the practical trading advantage is reduced; many institutions use aggregated trends across multiple managers rather than single filings to inform allocation decisions.

Q: How should allocators compare Weybosset’s 13F to peers? A: Compare sector weights, top-ten concentration, and position-to-float ratios on a like-for-like basis (same reporting date). Year-on-year changes and cross-manager composites yield better signals than one-off comparisons.